Blauvelt, A.; Stein Gold, L.; Gooderham, M.; Strober, B.; Pinter, A.; Carrascosa, J.-M.; Gisondi, P.; Bleier, J.; Madden, C.; Deherder, D.; Gomez, N. N.; Warren, R. B. Bimekizumab Efficacy and Safety through Two Years in Patients With Moderate Psoriasis: Analysis of Pooled Data from Five Phase 3/3b Clinical Trials. J of Skin 2022, 6, s67.